Skip to content

Goldman Sachs

US · GS #53 by market cap Listed 1999
881.86 -5.35 -0.60%
Live - 5344 symbols - heartbeat 47s ago · 2026-10-08 15:40
Pre-market 878.48 -0.98%
After-hours 888.37 +0.13%
Overnight 878.39 -0.99%
Market cap
256.77B
P/B
2.34
EPS
51.32
Reader sentiment Are you bullish or bearish on GS?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Company notice
    GS Yuasa: Amendment Report (Securities Subject to Special Treatment, etc.)
    EDINET · 2026/9/4
  • Company notice
    GS Yuasa: Amendment Report (Special-Case Eligible Share Certificates, etc.)
    EDINET · 2026/5/11
  • Rating change
    Wells Fargo Maintains Goldman Sachs(GS.US) With Buy Rating, Cuts Target Price to $1,175
    Market Newswire · 2026/9/25
  • Rating change
    Barclays Maintains Goldman Sachs(GS.US) With Buy Rating, Maintains Target Price $1,245
    Market Newswire · 2026/9/18
  • Company notice
    GS Yuasa: Supplementary Registration Documents (Share Certificates, Corporate Bond Certificates, etc.)
    EDINET · 2026/9/4
  • Rating change
    DBS Initiates Goldman Sachs(GS.US) With Buy Rating, Announces Target Price $1,200
    Market Newswire · 2026/8/6
  • Rating change
    Morgan Stanley Maintains Goldman Sachs(GS.US) With Hold Rating, Maintains Target Price $1,145
    Market Newswire · 2026/9/21
  • Rating change
    UBS Maintains Goldman Sachs(GS.US) With Hold Rating, Raises Target Price to $1,150
    Market Newswire · 2026/8/3
  • Rating change
    Jefferies Maintains Goldman Sachs(GS.US) With Buy Rating, Maintains Target Price $1,299
    Market Newswire · 2026/8/13
  • Rating change
    Citi Maintains Goldman Sachs(GS.US) With Hold Rating, Cuts Target Price to $1,050
    Market Newswire · 2026/9/23
  • Company notice
    GS Global: Changes in Goods and Services With Affiliated Company Invested by the Same Person, Etc.
    OPENDART · 2026/4/30
  • Rating change
    Analysts Conflicted on These Financial Names: Prudential Financial (PRU), W. R. Berkley Corporation (WRB) and Goldman Sachs Group (GS)
    TipRanks · 2026/7/16
  • Rating change
    A Quick Look at Today's Ratings for Goldman Sachs(GS.US), With a Forecast Between $1,190 to $1,300
    Market Newswire · 2026/7/16
  • Rating change
    RBC Capital Maintains Goldman Sachs(GS.US) With Hold Rating, Raises Target Price to $1,220
    Market Newswire · 2026/7/17
  • Wells Fargo Maintains Goldman Sachs(GS.US) With Buy Rating, Maintains Target Price $1,175
    Market Newswire · 2026/9/25
  • HSBC Initiates Goldman Sachs(GS.US) With Hold Rating, Announces Target Price $1,007
    Market Newswire · 2026/9/28
  • BofA Securities Maintains Goldman Sachs(GS.US) With Buy Rating, Maintains Target Price $1,300
    Market Newswire · 2026/9/30
  • RBC Capital Maintains Goldman Sachs(GS.US) With Hold Rating, Maintains Target Price $1,220
    Market Newswire · 2026/10/1
  • Company notice
    Medical Net: Newly launched: "Keihi Powder [Granules] GS" to alleviate thirst and dry mouth associated with elevated blood sugar levels.
    JPX · 2026/9/16
  • Goldman Sachs (GS.US) is reportedly set to promote Chief Operating Officer John Waldron to CEO as early as next year.
    AASTOCKS · 2026/9/29
  • Goldman Sachs (GS.US) warns: Warsh's reduction in transparency could lead to unwarranted market volatility
    Zhitong Finance · 9/11
  • Assembly Biosciences Says Assembly Bio Eligible For Up To $280M In Milestones And Royalties Outside U.S.; GS-1179 Expected To Advance Into Phase 2 Trial For Genital Herpes By End Of 2026; Assembly Bio Expects Cash Runway Into 2029
    Benzinga · 9/9
  • GS Engineering & Construction Secures KRW637.4 Billion Redevelopment Project
    MT Newswires · 9/10
  • Company notice
    GS Yuasa: Amendment Report (Special Cases of Target Share Certificates, etc.)
    EDINET · 4/3
  • Korean Privacy Regulator Fines GS Retail KRW12.8 Billion for Personal Data Breach
    MT Newswires · 9/1

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-08 15:40:14 · For reference only, not investment advice and not tailored to your situation.